C4X Discovery Holdings PLC
LSE:C4XD
Relative Value
The Relative Value of one C4XD stock under the Base Case scenario is 43.35 GBX. Compared to the current market price of 12 GBX, C4X Discovery Holdings PLC is Undervalued by 72%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
C4XD Competitors Multiples
C4X Discovery Holdings PLC Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
UK |
C4X Discovery Holdings PLC
LSE:C4XD
|
30.3m GBP | 1.2 | 2.9 | 1.8 | 1.8 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.3B USD | 5.2 | 36.9 | 22.8 | 33.4 | ||
US |
Danaher Corp
NYSE:DHR
|
184B USD | 4.2 | 22.8 | 16.6 | 20.4 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.5B CHF | 5.6 | 57.3 | 19.7 | 28.9 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
40.5B USD | 2.7 | 29.9 | 16.3 | 25.2 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.9B USD | 6.1 | 33.1 | 26.4 | 31.8 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64 | 33.7 | 48.6 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.2 | 23.9 | 26.5 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.6B USD | 9.1 | 46.9 | 32.5 | 39.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.6B USD | 3.1 | 37.4 | 16.9 | 26 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.4 | 32.4 | 53.2 |